Biomarkers for neonatal sepsis: recent developments

As a leading cause of neonatal morbidity and mortality, neonatal sepsis remains a significant global health challenge. Despite recent advances in the management of neonatal sepsis, including use of more potent antibiotics, timely identification continues to be a frequent and challenging problem in the management of the newborn or high-risk neonate in the neonatal intensive care unit. Lack of specific early objective diagnostic evaluations or specific signs and symptoms, especially in the preterm infant, impedes early identification. However, emerging technologies linked with enhanced understanding of the immature and developing neonatal immune system responses to early infection provide an opportunity to develop critically needed biomarkers to improve early identification in this high-risk population. This review will focus on the field of neonatal sepsis biomarker development, identifying current promising biomarkers that have been investigated and widely utilized, as well as provide insight into recent advances and the rapidly evolving technologies that are being exploited in biomarker development to improve diagnosis, treatment, and prognosis in neonatal sepsis.

[1]  G. Steinbach,et al.  Whole blood interleukin 8 and plasma interleukin 8 levels in newborn infants with suspected bacterial infection , 2004, Acta paediatrica.

[2]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[3]  C. Hammerman,et al.  Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram , 2006, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[4]  Shizuo Akira,et al.  The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.

[5]  H. Stockhausen,et al.  Interleukin‐6 and soluble interleukin‐6 receptor in cord blood in the diagnosis of early onset sepsis in neonates , 1995, Acta paediatrica.

[6]  C. O’Hern,et al.  Which Biomarkers Reveal Neonatal Sepsis? , 2013, PloS one.

[7]  C. Fanali,et al.  The Surprising Composition of the Salivary Proteome of Preterm Human Newborn , 2010, Molecular & Cellular Proteomics.

[8]  B. Resch,et al.  An Update on the Use of C-Reactive Protein in Early-Onset Neonatal Sepsis: Current Insights and New Tasks , 2012, Neonatology.

[9]  Peter A. Ward,et al.  Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.

[10]  M. Gahr,et al.  SEQUENTIAL DETERMINATION OF CRP, α1‐ANTITRYPSIN AND HAPTOGLOBIN IN NEONATAL SEPTICAEMIA , 1983 .

[11]  P. Ng,et al.  Biomarkers for Late-Onset Neonatal Sepsis: Cytokines and Beyond , 2010, Clinics in Perinatology.

[12]  Iain Mackenzie,et al.  Sepsis: definition, epidemiology, and diagnosis , 2007, BMJ : British Medical Journal.

[13]  R. C. Silveira,et al.  The role of sample collection timing on interleukin-6 levels in early-onset neonatal sepsis. , 2004, Jornal de pediatria.

[14]  S. Sriskandan,et al.  The immunology of sepsis , 2008, The Journal of pathology.

[15]  B. Poindexter,et al.  Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.

[16]  P. Ng,et al.  Diagnostic markers of infection in neonates , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[17]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[18]  H. Bada,et al.  Significance of serial C-reactive protein responses in neonatal infection and other disorders. , 1993, Pediatrics.

[19]  P. Kulkarni,et al.  Comparative Assessment of Cytokines and Other Inflammatory Markers for the Early Diagnosis of Neonatal Sepsis–A Case Control Study , 2013, PLoS ONE.

[20]  Geng Li,et al.  Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections , 2003, Archives of disease in childhood. Fetal and neonatal edition.

[21]  J. Steinke,et al.  Immunologic messenger molecules: cytokines, interferons, and chemokines. , 2010, The Journal of allergy and clinical immunology.

[22]  B. Resch,et al.  Procalcitonin, interleukin-6, C-reactive protein and leukocyte counts in infants with bronchiolitis. , 2003, The Pediatric infectious disease journal.

[23]  P. Ng,et al.  Diagnostic markers for neonatal sepsis , 2006, Current opinion in pediatrics.

[24]  F. Harrell,et al.  Heart Rate Characteristics: Novel Physiomarkers to Predict Neonatal Infection and Death , 2005, Pediatrics.

[25]  W. Müller,et al.  Procalcitonin and interleukin‐6 in the diagnosis of early‐onset sepsis of the neonate , 2003, Acta paediatrica.

[26]  B. Stoll,et al.  International perspective on early-onset neonatal sepsis. , 2010, Clinics in perinatology.

[27]  A. Mantovani,et al.  PENTRAXIN 3 AND C-REACTIVE PROTEIN IN SEVERE MENINGOCOCCAL DISEASE , 2009, Shock.

[28]  W. Göpel,et al.  Immature anti‐inflammatory response in neonates , 2004, Clinical and experimental immunology.

[29]  R. Rabin,et al.  Neutrophil CD11b expression as a diagnostic marker for early-onset neonatal infection. , 1998, The Journal of pediatrics.

[30]  Fabio Natale,et al.  C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[31]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[32]  T. Hansen,et al.  Rapid Detection of Microorganisms in Blood Cultures of Newborn Infants Utilizing an Automated Blood Culture System , 2000, Pediatrics.

[33]  R. Polin Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis , 2012, Pediatrics.

[34]  R. Procianoy,et al.  Evaluation of interleukin‐6, tumour necrosis factor‐α and interleukin‐1β for early diagnosis of neonatal sepsis , 1999 .

[35]  G. Perez-Perez,et al.  Maternal Antenatal Treatments Influence Initial Oral Microbial Acquisition in Preterm Infants , 2012, American Journal of Perinatology.

[36]  S. Opal,et al.  Future perspectives on regulating pro-and anti-inflammatory responses in sepsis. , 2011, Contributions to microbiology.

[37]  J. Lacroix,et al.  Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome* , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[38]  J. Maron,et al.  Great expectorations: the potential of salivary ‘omic’ approaches in neonatal intensive care , 2014, Journal of Perinatology.

[39]  P. Ng,et al.  Biochemical markers of neonatal sepsis. , 2008, Pathology.

[40]  F. Harrell,et al.  Heart rate characteristics: novel physiomarkers to predict neonatal infection and death. , 2005, Pediatrics.

[41]  E. Polati,et al.  Comparison of procalcitonin and C-reactive protein as markers of sepsis. , 2003, Critical care medicine.

[42]  Geng Li,et al.  Neutrophil CD64 Is a Sensitive Diagnostic Marker for Early-Onset Neonatal Infection , 2004, Pediatric Research.

[43]  Bairong Shen,et al.  Diagnosis Value of the Serum Amyloid A Test in Neonatal Sepsis: A Meta-Analysis , 2013, BioMed research international.

[44]  R. Procianoy,et al.  A influência do tempo de coleta sobre os níveis de interleucina-6 na sepse neonatal precoce , 2004 .

[45]  A. Martinot,et al.  Sepsis in neonates and children: Definitions, epidemiology, and outcome , 1997, Pediatric emergency care.

[46]  D. Henderson,et al.  Inflammatory and immunological markers in preterm infants: correlation with disease , 1996, Clinical and experimental immunology.

[47]  H. Kautiainen,et al.  Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. , 2001, Pediatrics.

[48]  A. Ohlsson,et al.  Intrapartum antibiotics for known maternal Group B streptococcal colonization. , 2009, The Cochrane database of systematic reviews.

[49]  A. Marx,et al.  Activation of Umbilical Cord Endothelial Cells and Fetal Inflammatory Response in Preterm Infants with Chorioamnionitis and Funisitis , 2005, Pediatric Research.

[50]  S. Bennett,et al.  Reference Ranges for Lymphocyte Counts of Neonates: Associations Between Abnormal Counts and Outcomes , 2012, Pediatrics.

[51]  Hannu Kautiainen,et al.  Increased CD11b-Density on Circulating Phagocytes as an Early Sign of Late-Onset Sepsis in Extremely Low-Birth-Weight Infants , 2005, Pediatric Research.

[52]  J. Sung,et al.  Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. , 2010, The Journal of clinical investigation.

[53]  P. Bartmann,et al.  Lipopolysaccharide binding protein in preterm infants , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[54]  J. Neu,et al.  Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis , 2009, Journal of Perinatology.

[55]  A. V. van Rossum,et al.  Procalcitonin as an early marker of infection in neonates and children. , 2004, The Lancet. Infectious diseases.

[56]  T. Fok,et al.  Editor's Focus , 2007, Pediatric Research.

[57]  C. Dorn,et al.  Determination of total interleukin-8 in whole blood after cell lysis. , 2000, Clinical chemistry.

[58]  Fei Wang,et al.  Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis , 2012, Critical Care.

[59]  P. Scott Plasma Lactoferrin Levels in Newborn Preterm Infants: Effect of Infection , 1989, Annals of clinical biochemistry.

[60]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[61]  S. Cousens,et al.  4 million neonatal deaths: When? Where? Why? , 2005, The Lancet.

[62]  M. Hacımustafaoğlu,et al.  Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants , 2009, Journal of Perinatology.

[63]  J. R. Moorman,et al.  Cytokine screening identifies NICU patients with Gram-negative bacteremia , 2011, Pediatric Research.

[64]  C. Rey,et al.  Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children , 2001, Intensive Care Medicine.

[65]  T. Yamada,et al.  Further Characterization of Serum Amyloid A4 as a Minor Acute Phase Reactant and a Possible Nutritional Marker , 2001, Clinical chemistry and laboratory medicine.

[66]  Stark Ar 超出生体重児に対する早期デキサメサゾン投与の有用性 : National Institute of Child Health and Human Development Neonatal research Network報告 (海外誌掲載論文の和文概要とそれに対するコメント) , 2001 .

[67]  R. Westendorp,et al.  Anti-inflammatory cytokine profile and mortality in febrile patients , 1998, The Lancet.

[68]  W. Borkowsky,et al.  Usefulness of Urinary Immune Biomarkers in the Evaluation of Neonatal Sepsis , 2013, Clinical pediatrics.

[69]  L. Lind,et al.  Serum amyloid A (SAA) protein and high‐sensitivity C‐reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults , 2005, Acta paediatrica.

[70]  G. Steinbach,et al.  Reduction of Unnecessary Antibiotic Therapy in Newborn Infants Using Interleukin-8 and C-Reactive Protein as Markers of Bacterial Infections , 1999, Pediatrics.

[71]  W. Benitz Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. , 2010, Clinics in perinatology.

[72]  G. Lipowsky,et al.  Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation , 1998, The Lancet.

[73]  F. Signore,et al.  C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. , 2003, Clinical chemistry.

[74]  M. Singer,et al.  Mechanisms of sepsis-induced organ dysfunction , 2007, Critical care medicine.

[75]  G. Takahashi,et al.  Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[76]  M. Gahr,et al.  Sequential determination of CRP, alpha 1-antitrypsin and haptoglobin in neonatal septicaemia. , 1984, Acta paediatrica Scandinavica.

[77]  L. Atzori,et al.  Metabolomics in neonatology: fact or fiction? , 2013, Seminars in fetal & neonatal medicine.

[78]  V. Bhandari,et al.  Hematologic Profile of Sepsis in Neonates: Neutrophil CD64 as a Diagnostic Marker , 2008, Pediatrics.

[79]  L. Du,et al.  Gram Stain-Specific-Probe-Based Real-Time PCR for Diagnosis and Discrimination of Bacterial Neonatal Sepsis , 2008, Journal of Clinical Microbiology.

[80]  O. Levy,et al.  Advances in pathogenesis and management of sepsis , 2007, Current opinion in infectious diseases.

[81]  M. Eichner,et al.  Evaluation of IL-8-Concentrations in Plasma and Lysed EDTA-Blood in Healthy Neonates and Those with Suspected Early Onset Bacterial Infection , 2004, Pediatric Research.

[82]  E. Jean-Baptiste Cellular Mechanisms in Sepsis , 2007, Journal of intensive care medicine.

[83]  M. Molyneux,et al.  The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children , 2010, Critical care.

[84]  R. Regev,et al.  Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis , 2007, Journal of Perinatology.

[85]  H. Nishida,et al.  The usefulness of serial C‐reactive protein measurement in managing neonatal infection , 1995, Acta paediatrica.

[86]  T. K. van den Berg,et al.  The macrophage scavenger receptor CD163. , 2005, Immunobiology.

[87]  R. Pathak,et al.  Performance Evaluation of Hematologic Scoring System in Early Diagnosis of Neonatal Sepsis , 2013, Journal of clinical neonatology.

[88]  I. Papassotiriou,et al.  Clinical Value of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Term Neonates with Infection or Sepsis: A Prospective Study , 2014, Mediators of inflammation.

[89]  N. Andrawes,et al.  Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis. , 2014, Cytokine.

[90]  Ofer Levy,et al.  Innate immunity of the newborn: basic mechanisms and clinical correlates , 2007, Nature Reviews Immunology.

[91]  C. Leclerc,et al.  Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.

[92]  R. Regev,et al.  The prognostic virtue of inflammatory markers during late-onset sepsis in preterm infants. , 2004, Journal of perinatal medicine.

[93]  C. Roy,et al.  Early diagnosis of neonatal septicemia by hematologic scoring system, C-reactive protein and serum haptoglobin. , 2012, Mymensingh medical journal : MMJ.

[94]  T F Fok,et al.  Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[95]  A. Kordek,et al.  Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood , 2008, Clinical chemistry and laboratory medicine.

[96]  S. Hojker,et al.  Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein , 2004, Intensive Care Medicine.

[97]  D. Tudehope,et al.  Early diagnosis of neonatal sepsis using a hematologic scoring system. , 1988, The Journal of pediatrics.

[98]  J. Eugen-Olsen suPAR – a future risk marker , 2011, Journal of internal medicine.

[99]  Chiang-Wen Lee,et al.  Recurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical characteristics and risk factors. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[100]  J. Hewitt,et al.  Early diagnosis of neonatal sepsis. , 1980, Pediatrics.

[101]  G. Escobar,et al.  Interpreting Complete Blood Counts Soon After Birth in Newborns at Risk for Sepsis , 2010, Pediatrics.

[102]  L. Pacifico,et al.  Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[103]  Luigi Atzori,et al.  Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis. , 2014, Early human development.

[104]  R. C. Silveira,et al.  Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis. , 1999, Acta paediatrica.

[105]  R. Ye,et al.  Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. , 2003, Blood.

[106]  Joy E. Lawn,et al.  4 million neonatal deaths: When? Where? Why? Neonatal survival 1. , 2005 .

[107]  S. Self,et al.  Neonatal Innate TLR-Mediated Responses Are Distinct from Those of Adults1 , 2009, The Journal of Immunology.

[108]  A. Gautier,et al.  C-reactive protein , 2005 .

[109]  R. Polin,et al.  Sepsis screen in neonates with evaluation of plasma fibronectin , 1987, The Pediatric infectious disease journal.

[110]  E. Petrakou,et al.  Interleukin-8 and Monocyte Chemotactic Protein-1 mRNA Expression in Perinatally Infected and Asphyxiated Preterm Neonates , 2006, Neonatology.

[111]  C. Härtel,et al.  Reduced IL‐10 production and ‐receptor expression in neonatal T lymphocytes , 2007, Acta paediatrica.

[112]  R. Polin,et al.  Biomarkers for late-onset neonatal sepsis , 2010, Genome Medicine.

[113]  E. Bilavsky,et al.  C‐reactive protein as a marker of serious bacterial infections in hospitalized febrile infants , 2009, Acta paediatrica.

[114]  S. Hodge,et al.  Multiple leucocyte activation markers to detect neonatal infection , 2004, Clinical and experimental immunology.

[115]  J. Doery,et al.  The value of C‐reactive protein measurement in the diagnosis of neonatal infection , 1990, Journal of paediatrics and child health.

[116]  B. Vohr,et al.  Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. , 2004, JAMA.

[117]  Gordon D. Brown Dectin-1: a signalling non-TLR pattern-recognition receptor , 2006, Nature Reviews Immunology.

[118]  N. Blau,et al.  Comparison of C-reactive protein and white blood cell count with differential in neonates at risk for septicaemia , 1995, European Journal of Pediatrics.

[119]  Anthony S McLean,et al.  Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.

[120]  C. Buhimschi,et al.  The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis. , 2010, Clinics in perinatology.

[121]  S. Moestrup,et al.  CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. , 2002, The international journal of biochemistry & cell biology.

[122]  T. Fok,et al.  Neutrophil CD64 Expression: A Sensitive Diagnostic Marker for Late-Onset Nosocomial Infection in Very Low Birthweight Infants , 2002, Pediatric Research.

[123]  Geng Li,et al.  Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. , 2006, Clinical chemistry.

[124]  J. Bienvenu,et al.  Procalcitonin as an Acute Phase Marker , 2001, Annals of clinical biochemistry.

[125]  J. Buttery,et al.  Blood cultures in newborns and children: optimising an everyday test , 2002, Archives of disease in childhood. Fetal and neonatal edition.

[126]  P. Caboni,et al.  New diagnostic possibilities in systemic neonatal infections: metabolomics. , 2014, Early human development.

[127]  A. Ohlsson,et al.  Accuracy of leukocyte indices and C‐reactive protein for diagnosis of neonatal sepsis: a critical review , 1994, The Pediatric infectious disease journal.

[128]  S. Mehr,et al.  Cytokines as markers of bacterial sepsis in newborn infants: a review , 2000, The Pediatric infectious disease journal.